Literature DB >> 18991289

Excessive CpG 1668 stimulation triggers IL-10 production by cDC that inhibits IFN-alpha responses by pDC.

Zoe Waibler1, Martina Anzaghe, Abdo Konur, Shizuo Akira, Werner Müller, Ulrich Kalinke.   

Abstract

Upon stimulation with a wide range of concentrations of CpG oligodeoxynucleotide 2216 (CpG 2216), plasmacytoid DC are induced to produce type I IFN (IFN-alpha/beta). In contrast, CpG 1668 shows a bell-shaped dose-response correlation, i.e. only intermediate but not high doses of CpG 1668 induce IFN-alpha/beta. Interestingly, high-dose CpG 1668 completely inhibited IFN-alpha responses induced by CpG 2216. Experiments using supernatant of high-dose CpG-1668-treated cells indicated that secreted inhibitor(s) mediated the IFN-alpha shut-off. Among modulating cytokines, IL-10 turned out to be one important negative regulator. In line with this, supernatants of IL-10-deficient DC cultures stimulated with high-dose CpG 1668 did not inhibit IFN-alpha production. Interestingly, high-dose CpG 1668 also inhibited IFN-alpha responses induced by the DNA-encoded mouse cytomegalovirus, whereas IFN-alpha responses induced by negative-strand RNA-encoded vesicular stomatitis virus were only marginally affected. Experiments with DC cultures devoid of TLR9 indicated that TLR9 was critically required to mediate stimulatory and modulatory signals by low and high concentrations of CpG 1668, respectively. Analysis of purified DC subsets showed that conventional DC were the main IL-10 producers, whereas plasmacytoid DC hardly produced any IL-10.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18991289     DOI: 10.1002/eji.200838184

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  21 in total

1.  Immunomodulatory nanoparticles ameliorate disease in the Leishmania (Viannia) panamensis mouse model.

Authors:  Alyssa L Siefert; Allison Ehrlich; María Jesús Corral; Karen Goldsmith-Pestana; Diane McMahon-Pratt; Tarek M Fahmy
Journal:  Biomaterials       Date:  2016-09-06       Impact factor: 12.479

2.  Liposomal resiquimod for the treatment of Leishmania donovani infection.

Authors:  Kevin J Peine; Gaurav Gupta; Deanna J Brackman; Tracey L Papenfuss; Kristy M Ainslie; Abhay R Satoskar; Eric M Bachelder
Journal:  J Antimicrob Chemother       Date:  2013-08-16       Impact factor: 5.790

3.  CpG-B oligodeoxynucleotides inhibit TLR-dependent and -independent induction of type I IFN in dendritic cells.

Authors:  Yi C Liu; Reginald C Gray; Gareth A D Hardy; John Kuchtey; Derek W Abbott; Steven N Emancipator; Clifford V Harding
Journal:  J Immunol       Date:  2010-02-24       Impact factor: 5.422

4.  TLR2 signaling depletes IRAK1 and inhibits induction of type I IFN by TLR7/9.

Authors:  Yi C Liu; Daimon P Simmons; Xiaoxia Li; Derek W Abbott; W Henry Boom; Clifford V Harding
Journal:  J Immunol       Date:  2012-01-06       Impact factor: 5.422

5.  Local Delivery of the Toll-Like Receptor 9 Ligand CpG Downregulates Host Immune and Inflammatory Responses, Ameliorating Established Leishmania (Viannia) panamensis Chronic Infection.

Authors:  Allison K Ehrlich; Olga L Fernández; Daniel Rodriguez-Pinto; Tiago M Castilho; Maria J Corral Caridad; Karen Goldsmith-Pestana; Nancy Gore Saravia; Diane McMahon-Pratt
Journal:  Infect Immun       Date:  2017-02-23       Impact factor: 3.441

6.  Interleukin 10 hampers endothelial cell differentiation and enhances the effects of interferon α on lupus endothelial cell progenitors.

Authors:  Alyssa M Cates; Victoria I Holden; Emily M Myers; Carolyne K Smith; Mariana J Kaplan; J Michelle Kahlenberg
Journal:  Rheumatology (Oxford)       Date:  2014-11-20       Impact factor: 7.580

7.  Altered Toll-like receptor 9 signaling in Mycobacterium avium subsp. paratuberculosis-infected bovine monocytes reveals potential therapeutic targets.

Authors:  Ryan J Arsenault; Yue Li; Pekka Maattanen; Erin Scruten; Kimberley Doig; Andrew Potter; Philip Griebel; Anthony Kusalik; Scott Napper
Journal:  Infect Immun       Date:  2012-10-31       Impact factor: 3.441

8.  Gene expression profiling in the lungs of pigs with different susceptibilities to Glässer's disease.

Authors:  Jamie M Wilkinson; Carole A Sargent; Lucina Galina-Pantoja; Alexander W Tucker
Journal:  BMC Genomics       Date:  2010-07-29       Impact factor: 3.969

9.  Antibody-antigen-adjuvant conjugates enable co-delivery of antigen and adjuvant to dendritic cells in cis but only have partial targeting specificity.

Authors:  Martin Kreutz; Benoit Giquel; Qin Hu; Ram Abuknesha; Satoshi Uematsu; Shizuo Akira; Frank O Nestle; Sandra S Diebold
Journal:  PLoS One       Date:  2012-07-10       Impact factor: 3.240

10.  Ig-like transcript 7, but not bone marrow stromal cell antigen 2 (also known as HM1.24, tetherin, or CD317), modulates plasmacytoid dendritic cell function in primary human blood leukocytes.

Authors:  Barbara Tavano; Rui Pedro Galao; David R Graham; Stuart J D Neil; Veronica N Aquino; Dietmar Fuchs; Adriano Boasso
Journal:  J Immunol       Date:  2013-02-11       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.